Inari Medical Inc (NARI)
Financial leverage ratio
Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total assets | US$ in thousands | 674,235 | 548,835 | 524,968 | 506,534 | 504,152 | 487,819 | 484,262 | 484,109 | 311,542 | 292,427 | 253,559 | 234,577 | 214,092 | 205,811 | 224,354 |
Total stockholders’ equity | US$ in thousands | 464,910 | 452,142 | 435,645 | 426,736 | 417,002 | 415,099 | 413,778 | 418,812 | 239,209 | 234,370 | 221,821 | 213,611 | 200,254 | 191,484 | 183,870 |
Financial leverage ratio | 1.45 | 1.21 | 1.21 | 1.19 | 1.21 | 1.18 | 1.17 | 1.16 | 1.30 | 1.25 | 1.14 | 1.10 | 1.07 | 1.07 | 1.22 |
December 31, 2023 calculation
Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $674,235K ÷ $464,910K
= 1.45
The financial leverage ratio of Inari Medical Inc has been fluctuating over the past eight quarters, ranging from 1.16 to 1.45. The ratio indicates that, on average, the company finances its assets with more debt than equity. There was an increase in the financial leverage ratio in Q4 2023 compared to the prior quarter, reaching 1.45, which suggests a higher reliance on debt to fund its operations. This increase should be carefully monitored as it may indicate a potential increase in financial risk for the company. Overall, a consistent monitoring of the financial leverage ratio is essential for assessing the company's capital structure and risk profile.
Peer comparison
Dec 31, 2023